Very Low Density Lipoprotein in Patients with Gout

Total Page:16

File Type:pdf, Size:1020Kb

Very Low Density Lipoprotein in Patients with Gout Ann Rheum Dis: first published as 10.1136/ard.44.6.390 on 1 June 1985. Downloaded from Annals of the Rheumatic Diseases, 1985, 44, 390-394 Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout D G MACFARLANE, C A MIDWINTER, P A DIEPPE, C H BOLTON, AND M HARTOG From the University Department of Medicine, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HU, Avon SUMMARY The very low density (VLDL) apolipoproteins of 12 male patients with gout have been studied by analytical isoelectric focusing. The relative percentage distribution of the C apolipoproteins was calculated and compared with that from 12 normolipidaemic and 12 'lipid-matched' controls. In the gout patients apolipoprotein CII (apo CII) represented 19-6% of the VLDL C proteins and the CII/CIII2 ratio was 0-57. In the normolipidaemic controls apo CII represented 28*8% and in the lipid-matched controls 33*1% of VLDL apo C, and the CII/C0112 ratio approached one in each control group. These differences were significant. This suggests that a reduction in VLDL apo CII may predispose to the hypertriglyceridaemia that is commonly found in patients with gout. copyright. Key words: gout, hyperlipidaemia, apolipoprotein CII. Many studies have shown a high incidence of had been approved by the local ethical committee. hyperlipidaemia in patients with gout, commonly All their drug treatment was stopped for a period of hypertnxglyceridaemia due to raised endogenous six weeks, and they were also requested to reduce http://ard.bmj.com/ VLDL. -3 As well as lipid, VLDL particles contain their alcohol intake as much as possible and avoid B, C, and E apoproteins, and recent discoveries self medication. At the end of the six-week period about the function of these have had considerable serum was obtained after a 12-hour overnight fast. impact on the understanding of disorders of lipid metabolism. Lipoprotein lipase (LPL) catalyses the CONTROLS conversion of VLDL to LDL at capillary endothelial Serum from fasting subjects was obtained from two sites.4 5 Apo CII is an activator6 of LPL, and apo control groups. One group consisted of 12 normoli- on September 27, 2021 by guest. Protected CIII has been reported to inhibit this enzyme in pidaemic, normouricaemic men (mean age 34-5 vitro.7 years) with a normal social alcohol intake drawn To date, studies of hypertriglyceridaemia in gout from the hospital laboratory and medical staff. The have concentrated on the lipid moiety. The purpose other consisted of 12 normouricaemic men (mean of this study was to look for an abnormality in the C age 46) without a history of gout, who were matched apoprotein component of VLDL in men with gout, in lipid status with the gout patients: type IV (five which might explain their predisposition to hyper- patients), type Ilb (two patients), and five normo- triglyceridaemia. lipidaemic patients. SUBJECTS ASSESSMENT OF LIPID STATUS Twelve men with gout (mean age of 48 years) were Cholesterol was measured by cholesterol oxidase selected at random from the rheumatology clinic. and triglyceride by enzymatic assay after enzymatic They all gave informed consent to the study which hydrolysis (Boehringer Mannheim GmbH Diagnos- Accepted for publication 20 December 1984. tica). Patients were classifed into Fredrickson hyper- Correspondence to Dr D G Macfarlane, Lewisham Hospital, lipidaemia types according to the appearance of Lewisham High Street, London SE13 6LH. serum before and after standing for 24 hours at 4°C, 390 Ann Rheum Dis: first published as 10.1136/ard.44.6.390 on 1 June 1985. Downloaded from Very low density apolipoproteins 391 the serum lipid levels, and, where indicated, acetic acid v/v for a further 30 minutes to remove lipoprotein electrophoresis.' ampholine from the gel, and finally stained with 0*25% Coomassie brilliant blue according to the PREPARATION OF VLDL APOPROTEINS method of Weber and Osborn." VLDL was isolated from serum of fasting patients by ultracentrifugation9 in an MSE Prepspin 50 and IDENTIFICATION OF THE PROTEIN BANDS was subjected to a further 18-hour period of Each protein band was identified by its isoelectric ultracentrifugation at 40 000 rpm to remove any point (pl) from a standard graph prepared by contaminating albumin. The washed VLDL (con- running 20 samples under identical conditions and taining 1-5-3-0 g/l protein) was delipidated with cutting the unfixed gels into 2 mm segments which tetramethylurea (TMU).'0 were soaked for 24 hours in 1 ml deionised water. 300 iil VLDL was added to 300 ,tl 4-2 M TMU in The pH of each segment was measured and a scatter a small glass tube. The contents were mixed and diagram prepared by plotting the pH of each incubated at 37°C for 30 minutes. The tube was then segment against the positions of that segment along centrifuged at 2500 rpm for 10 minutes, and the the gel. A linear least mean square analysis gener- supernatant containing TMU-soluble apoproteins ated a straight line in the pH region 4-2-6-2, and a pl was removed and subjected to analytical isoelectric was determined for each band by measuring the focusing in polyacrylamide gel rods. distance along the gel, making allowance for gel shrinkage that occurred during fixing and staining. ANALYTICAL ISOELECTRIC FOCUSING The four major anodal bands were assigned on the Gel preparation basis of their pl to each of the four major apo C Polyacrylamide gels were prepared by mixing the proteins by reference to the published literature12 following solutions: 2-4 ml of 13-75% acrylamide and previous work from this department.)3 w/v-0*8% N,N-methylene bis(acrylamide) w/v in 8 M urea; 7 5 ml 8 M urea; 1-2 ml glycerol; 0-5 ml copyright. N,N,N'N'-tetramethylethylenediamine; and 0-6 ml QUANTIFICATION OF APO C ampholine pH 4-6 (LKB Produckter). Chemical The stained gels were scanned at 560 nm in a Pye polymerisation was carried out by adding 0 15 ml of Unicam (SP800) spectrophotometer fitted with a gel a 1-07% solution of ammonium persulphate w/v in 8 scanning attachment. The peak area (heightxwidth M urea, and the gels were cast to a height of 10-5 cm at ½/2 peak height) was calculated for each apo C in 0-5 x 12 cm glass tubes. The final concentration of band, and the contribution of each individual band urea was 6-8 M and of acrylamide 7-5%. was expressed as a percentage of the total area of quantified apo C. The within-assay coefficient of http://ard.bmj.com/ ELECTROFOCUSING variation was 2%, and between-assay coefficient of A disc gel electrophoresis apparatus (Shandon variation ranged from 2-7 to 7%. Scientific Co. Ltd) was adapted for isoelectric Previous work in this department'3 has estab- focusing by fitting a Perspex extension collar to lished that this method of quantification is valid. accommodate the longer gels. The lower electrode The absorption of the bands produced by the C chamber was filled with 250 ml of 0-1 M phosphoric apoproteins is linear over a wide ran e. This has also acid and the upper with 240 ml 0*1 M NaOH. The been confirmed by other workers. on September 27, 2021 by guest. Protected gels were run at a constant voltage with a current of 1 mA per tube for one hour to remove the STATISTICAL ANALYSIS persulphate and partially establish the pH gradient. The differences observed in the distribution of C 50 RI of a solution consisting of 2-5% v/v ampholine apoproteins in the three groups were tested for pH 4-6 in 5% w/v sucrose solution was then carefully statistical significance by Wilcoxon's rank sum test placed on top of each gel, and 100 Rl of delipidated for unpaired data. VLDL solution layered underneath this. A constant voltage of 44 V per tube was then applied for 24 Results hours at room temperature. Each sample was run in duplicate. No overheating was experienced with up Relevant clinical findings in the gout patients are to six tubes run simultaneously. shown in Table 1 and their serum and VLDL cholesterol and triglyceride levels in Table 2. The GEL FIXING AND STAINING serum and VLDL cholesterol and triglyceride level Gels were first fixed in a 11*5% w/v trichloracetic of the lipid-matched controls are shown in Table 3. acid +3-46% w/v sulphosalicylic acid mixture for 30 Seven of the 12 gout patients (58%) had a minutes, then washed with 25% ethanol v/v +8% hyperlipidaemia: five type IV and two type lIb. Ann Rheum Dis: first published as 10.1136/ard.44.6.390 on 1 June 1985. Downloaded from 392 Macfarlane, Midwinter, Dieppe, Bolton, Hartog Table 1 Clinical and laboratory features of the gout Table 3 Serum and VLDL levels in normouricaemic patients lipid-matched controls Patient Age SUA* Obesityt Alcohol Typet Matched Triglyceride Cholesterol Type* (mmolNl) intake control (mmol/l) (mmol/l) 1 38 0-44 - + N Total VLDL Total VLDL 2 53 0-42 - + N 3 30 0-54 - + + N 1 1-68 0-84 6-42 0-46 N 4 56 0-54 - + N 2 1-48 1-09 6-84 0-53 N 5 73 0-63 + + N 3 1-36 1-06 7-23 0-71 N 6 42 0-5 + + IV 4 1-52 0-94 8-23 0-92 N 7 43 0-42 + + IV 5 2-24 0-76 6-92 1-10 N 8 61 0-62 + + IV 6 3-35 2-66 7-41 1-30 IV 9 40 0-44 - + IV 7 2-87 1-78 8-64 1-42 IV 10 52 0-55 - 0 IV 8 4-88 2-22 6-84 0-68 IV 11 56 0-5 - 0 lIb 9 6-40 4-34 8-23 1-45 IV 12 37 0-54 - 0 IIb 10 3-86 2-02 7-30 1-09 IV 11 3-42 1-87 8-90 2-30 lIb *Serum uric acid.
Recommended publications
  • Technical Note: Colorimetric Protein Assays Assays for Determining Protein Concentration
    Technical Note: Colorimetric Protein Assays Assays for Determining Protein Concentration Contents speed. No colorimetric assay is as simple and quick as direct UV measurements at 280 nm for Introduction ....................................................... 1 the determination of protein concentration. Assay Choice ..................................................... 1 However measurements at 280 nm rely on the Buffer Composition ........................................ 1 protein containing aromatic amino acids such as Sample Composition ...................................... 2 tyrosine (Y), phenylalanine (F), and, or tryptophan Standard Selection ......................................... 2 (W). Not all proteins contain these amino acids, Assays ................................................................ 2 and the relative proportions of theses amino acids Biuret, BCA, and Lowry Assays ..................... 3 differ between proteins. Furthermore, if nucleic Bradford Assay............................................... 3 acids are present in the sample, they would also Troubleshooting ............................................. 4 absorb light at 280 nm, further compromising FAQ’s .................................................................. 5 accuracy. Therefore, the sensitivity achieved Bibliography ...................................................... 5 without prior knowledge of the protein of interest’s Contact Us ......................................................... 6 absorbance maxima (λmax) and attenuation coefficient
    [Show full text]
  • 35 Disorders of Purine and Pyrimidine Metabolism
    35 Disorders of Purine and Pyrimidine Metabolism Georges van den Berghe, M.- Françoise Vincent, Sandrine Marie 35.1 Inborn Errors of Purine Metabolism – 435 35.1.1 Phosphoribosyl Pyrophosphate Synthetase Superactivity – 435 35.1.2 Adenylosuccinase Deficiency – 436 35.1.3 AICA-Ribosiduria – 437 35.1.4 Muscle AMP Deaminase Deficiency – 437 35.1.5 Adenosine Deaminase Deficiency – 438 35.1.6 Adenosine Deaminase Superactivity – 439 35.1.7 Purine Nucleoside Phosphorylase Deficiency – 440 35.1.8 Xanthine Oxidase Deficiency – 440 35.1.9 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency – 441 35.1.10 Adenine Phosphoribosyltransferase Deficiency – 442 35.1.11 Deoxyguanosine Kinase Deficiency – 442 35.2 Inborn Errors of Pyrimidine Metabolism – 445 35.2.1 UMP Synthase Deficiency (Hereditary Orotic Aciduria) – 445 35.2.2 Dihydropyrimidine Dehydrogenase Deficiency – 445 35.2.3 Dihydropyrimidinase Deficiency – 446 35.2.4 Ureidopropionase Deficiency – 446 35.2.5 Pyrimidine 5’-Nucleotidase Deficiency – 446 35.2.6 Cytosolic 5’-Nucleotidase Superactivity – 447 35.2.7 Thymidine Phosphorylase Deficiency – 447 35.2.8 Thymidine Kinase Deficiency – 447 References – 447 434 Chapter 35 · Disorders of Purine and Pyrimidine Metabolism Purine Metabolism Purine nucleotides are essential cellular constituents 4 The catabolic pathway starts from GMP, IMP and which intervene in energy transfer, metabolic regula- AMP, and produces uric acid, a poorly soluble tion, and synthesis of DNA and RNA. Purine metabo- compound, which tends to crystallize once its lism can be divided into three pathways: plasma concentration surpasses 6.5–7 mg/dl (0.38– 4 The biosynthetic pathway, often termed de novo, 0.47 mmol/l). starts with the formation of phosphoribosyl pyro- 4 The salvage pathway utilizes the purine bases, gua- phosphate (PRPP) and leads to the synthesis of nine, hypoxanthine and adenine, which are pro- inosine monophosphate (IMP).
    [Show full text]
  • Pro-Aging Effects of Xanthine Oxidoreductase Products
    antioxidants Review Pro-Aging Effects of Xanthine Oxidoreductase Products , , Maria Giulia Battelli y , Massimo Bortolotti y , Andrea Bolognesi * z and Letizia Polito * z Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy; [email protected] (M.G.B.); [email protected] (M.B.) * Correspondence: [email protected] (A.B.); [email protected] (L.P.); Tel.: +39-051-20-9-4707 (A.B.); +39-051-20-9-4729 (L.P.) These authors contributed equally. y Co-last authors. z Received: 22 July 2020; Accepted: 4 September 2020; Published: 8 September 2020 Abstract: The senescence process is the result of a series of factors that start from the genetic constitution interacting with epigenetic modifications induced by endogenous and environmental causes and that lead to a progressive deterioration at the cellular and functional levels. One of the main causes of aging is oxidative stress deriving from the imbalance between the production of reactive oxygen (ROS) and nitrogen (RNS) species and their scavenging through antioxidants. Xanthine oxidoreductase (XOR) activities produce uric acid, as well as reactive oxygen and nitrogen species, which all may be relevant to such equilibrium. This review analyzes XOR activity through in vitro experiments, animal studies and clinical reports, which highlight the pro-aging effects of XOR products. However, XOR activity contributes to a regular level of ROS and RNS, which appears essential for the proper functioning of many physiological pathways. This discourages the use of therapies with XOR inhibitors, unless symptomatic hyperuricemia is present.
    [Show full text]
  • Thermostable and Long-Circulating Albumin-Conjugated Arthrobacter Globiformis Urate Oxidase
    pharmaceutics Article Thermostable and Long-Circulating Albumin-Conjugated Arthrobacter globiformis Urate Oxidase Byungseop Yang and Inchan Kwon * School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-62-715-2312 Abstract: Urate oxidase derived from Aspergillus flavus has been investigated as a treatment for tumor lysis syndrome, hyperuricemia, and gout. However, its long-term use is limited owing to potential immunogenicity, low thermostability, and short circulation time in vivo. Recently, urate oxidase isolated from Arthrobacter globiformis (AgUox) has been reported to be thermostable and less immunogenic than the Aspergillus-derived urate oxidase. Conjugation of human serum albumin (HSA) to therapeutic proteins has become a promising strategy to prolong circulation time in vivo. To develop a thermostable and long-circulating urate oxidase, we investigated the site-specific conjugation of HSA to AgUox based on site-specific incorporation of a clickable non-natural amino acid (frTet) and an inverse electron demand Diels–Alder reaction. We selected 14 sites for frTet incorporation using the ROSETTA design, a computational stability prediction program, among which AgUox containing frTet at position 196 (Ag12) exhibited enzymatic activity and thermostability comparable to those of wild-type AgUox. Furthermore, Ag12 exhibited a high HSA conjugation yield without compromising the enzymatic activity, generating well-defined HSA-conjugated AgUox (Ag12-HSA). In mice, the serum half-life of Ag12-HSA was approximately 29 h, which was roughly Citation: Yang, B.; Kwon, I. 17-fold longer than that of wild-type AgUox. Altogether, this novel formulated AgUox may hold Thermostable and Long-Circulating enhanced therapeutic efficacy for several diseases.
    [Show full text]
  • UDP-N-Acetylglucosamine Transporter and UDP-Galactose Transporter
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 586 (2012) 4082–4087 journal homepage: www.FEBSLetters.org UDP-N-acetylglucosamine transporter and UDP-galactose transporter form heterologous complexes in the Golgi membrane ⇑ Dorota Maszczak-Seneczko a, Paulina Sosicka a, Michał Majkowski b, Teresa Olczak a, Mariusz Olczak a, a Laboratory of Biochemistry, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland b Laboratory of Cytobiochemistry, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland article info abstract Article history: UDP-galactose transporter (UGT; SLC35A2) and UDP-N-acetylglucosamine transporter (NGT; Received 6 August 2012 SLC35A3) are evolutionarily related. We hypothesize that their role in glycosylation may be coupled Revised 2 October 2012 through heterologous complex formation. Coimmunoprecipitation analysis and FLIM–FRET mea- Accepted 8 October 2012 surements performed on living cells showed that NGT and UGT form complexes when overexpressed Available online 23 October 2012 in MDCK-RCAr cells. We also postulate that the interaction of NGT and UGT may explain the dual Edited by Judit Ovádi localization of UGT2. For the first time we demonstrated in vivo homodimerization of the NGT nucle- otide sugar transporter. In conclusion, we suggest that NGT and UGT function in glycosylation is combined via their mutual interaction. Keywords: UDP-N-acetylglucosamine transporter UDP-galactose transporter Structured summary
    [Show full text]
  • Step-By-Step Guide to Better Laboratory Management Practices
    Step-by-Step Guide to Better Laboratory Management Practices Prepared by The Washington State Department of Ecology Hazardous Waste and Toxics Reduction Program Publication No. 97- 431 Revised January 2003 Printed on recycled paper For additional copies of this document, contact: Department of Ecology Publications Distribution Center PO Box 47600 Olympia, WA 98504-7600 (360) 407-7472 or 1 (800) 633-7585 or contact your regional office: Department of Ecology’s Regional Offices (425) 649-7000 (509) 575-2490 (509) 329-3400 (360) 407-6300 The Department of Ecology is an equal opportunity agency and does not discriminate on the basis of race, creed, color, disability, age, religion, national origin, sex, marital status, disabled veteran’s status, Vietnam Era veteran’s status or sexual orientation. If you have special accommodation needs, or require this document in an alternate format, contact the Hazardous Waste and Toxics Reduction Program at (360)407-6700 (voice) or 711 or (800) 833-6388 (TTY). Table of Contents Introduction ....................................................................................................................................iii Section 1 Laboratory Hazardous Waste Management ...........................................................1 Designating Dangerous Waste................................................................................................1 Counting Wastes .......................................................................................................................8 Treatment by Generator...........................................................................................................12
    [Show full text]
  • Disclosing the Essentiality of Ribose-5-Phosphate Isomerase B In
    www.nature.com/scientificreports OPEN Disclosing the essentiality of ribose-5-phosphate isomerase B in Trypanosomatids Received: 04 January 2016 Joana Faria1,2, Inês Loureiro1,2, Nuno Santarém1,2, Pedro Cecílio1,2, Sandra Macedo-Ribeiro2,3, Accepted: 10 May 2016 Joana Tavares1,2,* & Anabela Cordeiro-da-Silva1,2,4,* Published: 27 May 2016 Ribose-5-phosphate isomerase (RPI) belongs to the non-oxidative branch of the pentose phosphate pathway, catalysing the inter-conversion of D-ribose-5-phosphate and D-ribulose-5-phosphate. Trypanosomatids encode a type B RPI, whereas humans have a structurally unrelated type A, making RPIB worthy of exploration as a potential drug target. Null mutant generation in Leishmania infantum was only possible when an episomal copy of RPIB gene was provided, and the latter was retained both in vitro and in vivo in the absence of drug pressure. This suggests the gene is essential for parasite survival. Importantly, the inability to remove the second allele of RPIB gene in sKO mutants complemented with an episomal copy of RPIB carrying a mutation that abolishes isomerase activity suggests the essentiality is due to its metabolic function. In vitro, sKO promastigotes exhibited no defect in growth, metacyclogenesis or macrophage infection, however, an impairment in intracellular amastigotes’ replication was observed. Additionally, mice infected with sKO mutants rescued by RPIB complementation had a reduced parasite burden in the liver. Likewise, Trypanosoma brucei is resistant to complete RPIB gene removal and mice infected with sKO mutants showed prolonged survival upon infection. Taken together our results genetically validate RPIB as a potential drug target in trypanosomatids.
    [Show full text]
  • IER5 Is Involved in DNA Double-Strand Breaks Repair In
    Int. J. Med. Sci. 2017, Vol. 14 1292 Ivyspring International Publisher International Journal of Medical Sciences 2017; 14(12): 1292-1300. doi: 10.7150/ijms.21510 Research Paper IER5 is involved in DNA Double-Strand Breaks Repair in Association with PAPR1 in Hela Cells Xin-Ping Yu1, Yu-Mei Wu1, Yang Liu1, Ming Tian1, Jian-Dong Wang1, Ku-Ke Ding2, Teng Ma3, Ping-Kun Zhou3 1. Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100006, China; 2. National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing ,100088, China; 3. Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China. Corresponding author: Yu-Mei Wu, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, 17 Qi-he-lou St, Dongcheng District, Beijing 100006, China. E-mail: [email protected] © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2017.06.17; Accepted: 2017.09.01; Published: 2017.09.30 Abstract The immediate early response gene 5 (IER5) is a radiation response gene induced in a dose-independent manner, and has been suggested to be a molecular biomarker for biodosimetry purposes upon radiation exposure. Here, we investigated the function of IER5 in DNA damage response and repair. We found that interference on IER5 expression significantly decreased the efficiency of repair of DNA double-strand breaks induced by ionizing radiations in Hela cells.
    [Show full text]
  • Evaluation of Signaling Pathways Profiling in Human Dermal
    toxins Article Evaluation of Signaling Pathways Profiling in Human Dermal Endothelial Cells Treated by Snake Venom Cysteine-Rich Secretory Proteins (svCRiSPs) from North American Snakes Using Reverse Phase Protein Array (RPPA) Montamas Suntravat 1,2,* , Oscar Sanchez 1, Armando Reyes 1, Abcde Cirilo 1, Jack S. Ocheltree 1, Jacob A. Galan 1,2, Emelyn Salazar 1 , Peter Davies 3 and Elda E. Sanchez 1,2 1 National Natural Toxins Research Center (NNTRC), Texas A&M University-Kingsville, MSC 224, 975 West Avenue B, Kingsville, TX 78363, USA; [email protected] (O.S.); [email protected] (A.R.); [email protected] (A.C.); [email protected] (J.S.O.); [email protected] (J.A.G.); [email protected] (E.S.); [email protected] (E.E.S.) 2 Department of Chemistry, Texas A&M University-Kingsville, MSC 161, Kingsville, TX 78363, USA 3 Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77843, USA; [email protected] * Correspondence: [email protected] Abstract: Cysteine-Rich Secretory Proteins (CRiSPs) are typically found in many snake venoms; however, the role that these toxins play in the pathophysiology of snakebites is still unclear. Herein, we compared the effects of snake venom CRiSPs (svCRiSPs) from the most medically important Citation: Suntravat, M.; Sanchez, O.; species of North American snakes on endothelial cell permeability and vascular permeability. We Reyes, A.; Cirilo, A.; Ocheltree, J.S.; used reverse phase protein array (RPPA) to identify key signaling molecules on human dermal Galan, J.A.; Salazar, E.; Davies, P.; lymphatic (HDLECs) and blood (HDBECs) endothelial cells treated with svCRiSPs.
    [Show full text]
  • Alternative Pathways of Glucose Metabolism II. Nucleotides from The
    Alternative Pathways of Glucose Metabolism II . Nucleotides from the Acid-soluble Fraction of Normal and Tumor Tissues and Studies on Nucleic Acid Synthesis in Tumors*t HANNS SCHMITZ4 VAN R. POTTER, ROBERT B. HTJRLBERT,@ AND DWAIN M. WHITE (McArdie Memovial Laboratory, the Medical School, University of Wisconain, Madison, WI..) The first paper (18) in this series on the alterna MATERIALS AND METHODS tive pathways of glucose metabolism established The present study has involved the measure the fact that radioactivity from glucose-i-C'4 was ment of the specific activities of the free 5' mono-, readily incorporated into the pentose moiety of the di-, and triphosphates of adenosine, guanosine, ribonucleic and desoxyribonucleic acids of Flexner cytidine, and uridine from the acid-soluble extract Jobling tumors in rats, and described the over-all of tumor tissue in relation to the specific activities distribution of radioactivity in the acid-soluble of the corresponding nucleotides that were oh and acid-insoluble fractions of tumor and liver tis tamed by chemical or enzymatic hydrolysis of the sue at various time periods. The acid-soluble frac nucleic acids from the same tissue samples, at tion of tissue contains an appreciable amount of specified time intervals after the injection of glu free nucleotides which are possible intermediary cose-1-C'4. The experimental plan corresponds compounds in the synthesis of the nucleic acids exactly to that described in the preceding paper; (6, 7, 8, 9, 13, 16). It was noted (18) that as the C'4 many of
    [Show full text]
  • Low Uric Acid Diet Diet FAQ's What Is Uricvs Acid? Uric Acid Is a Byproduct of Purines (PYUR-Eenz)
    o ?? ou need t Y our reduce y Uric Acid! Understanding the Low Uric Acid Diet Diet FAQ's What is Uricvs Acid? Uric acid is a byproduct of purines (PYUR-eenz). Purines are naturally occurring substances and are found in many food items. As purines are broken down in the body, they are eliminated as uric acid. What does Uric Acid have to do with CKD? Normally, uric acid passes through the kidneys and is excreted in urine. However, when the kidneys cannot process all of the uric acid, hyperuricemia, or elevated uric acid in the blood, may develop. Recent research has determined that approximately 10% of Americans with Chronic Kidney Disease (CKD) also have gout, and if left untreated, can further worsen kidney function. Why do I need a diet that reduces Uric Acid? When your kidneys are not functioning properly, they do not filter out uric acid properly, thus potentially leading to a number of health issues. Elevated hyperuricemia (elevated uric acid levels) may cause: • Worsening of kidney function • Flare up of gout • Damage to affected joints Diet Do's and Don'ts Do Don't DO Don't Do Don't Exercise: even 1 minute of moderate to brisk Don’t take baker’s yeast or brewer’s yeast as a walking is helpful supplement Drink 8-12 cups o f fluid daily, this may help reduce Don't drink ( or try to limit) alcohol. Alcohol increases kidney stone formation and decrease uric acid purine production, thus further worsening crystals hyperuricemia Foods to limit Limit meat to 3 ounces per meal Limit high fat foods, such as salad dressings, ice cream, fried foods, & gravies.
    [Show full text]
  • Study of Purine Metabolism in a Xanthinuric Female
    Study of Purine Metabolism in a Xanthinuric Female MICHAEL J. BRADFORD, IRWIN H. KRAKOFF, ROBERT LEEPER, and M. EARL BALis From the Sloan-Kettering Institute, Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences, and the Department of Medicine of Memorial and James Ewing Hospitals, New York 10021 A B S TR A C T A case of xanthinuria is briefly de- Case report in brief. The patient is a 62 yr old scribed, and the results of in vivo studies with Puerto Rican grandmother, whose illness is de- 4C-labeled oxypurines are discussed. The data scribed in detail elsewhere.' Except for mild pso- demonstrate that the rate of the turnover of uric riasis present for 30 yr, she has been in good acid is normal, despite an extremely small uric health. On 26 June 1966, the patient was admitted acid pool. Xanthine and hypoxanthine pools were to the Second (Cornell) Medical Service, Bellevue measured and their metabolism evaluated. The Hospital, with a 3 day history of pain in the right bulk of the daily pool of 276 mg of xanthine, but foot and fever. The admission physical examina- only 6% of the 960 mg of hypoxanthine, is ex- tion confirmed the presence of monoarticular ar- creted. Thus, xanthine appears to be a metabolic thritis and mild psoriasis. The patient's course in end product, whereas hypoxanthine is an active the hospital was characterized by recurrent fevers intermediate. Biochemical implications of this find- to 104°F and migratory polyarthritis, affecting ing are discussed. both ankles, knees, elbows, wrists, and hands over a 6 wk period.
    [Show full text]